SCHEMBL17540751

SCHEMBL17540751

CCCCCCC/C=C/C=C\C(=O)O

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 2/20 0.67
FASN P49327 1/20 0.67
KDM4E B2RXH2 1/20 0.65
CNR1 P21554 2/20 0.57
CNR2 P34972 2/20 0.57
FAAH O00519 2/20 0.56
TERT O14746 2/20 0.55
GMNN O75496 1/20 0.55
USP2 O75604 1/20 0.55
LMNA P02545 1/20 0.55
CYP1A2 P05177 1/20 0.55
POLB P06746 1/20 0.55
MAPT P10636 1/20 0.55
CYP2C9 P11712 1/20 0.55
ALOX15 P16050 1/20 0.55
APEX1 P27695 1/20 0.55
CYP2C19 P33261 1/20 0.55
RECQL P46063 1/20 0.55
BLM P54132 1/20 0.55
NPSR1 Q6W5P4 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2785794 1.00 PTPN1 (0.67) PTPN1FASNKDM4ECNR1CNR2
SCHEMBL7806557 1.00 PTPN1 (0.67) PTPN1FASNKDM4ECNR1CNR2
SCHEMBL6556128 1.00 PTPN1 (0.67) PTPN1FASNKDM4ECNR1CNR2
SCHEMBL1614406 1.00 PTPN1 (0.67) PTPN1FASNKDM4ECNR1CNR2
SCHEMBL2059489 1.00 PTPN1 (0.67) PTPN1FASNKDM4ECNR1CNR2
SCHEMBL3793137 1.00 PTPN1 (0.67) PTPN1FASNKDM4ECNR1CNR2
SCHEMBL23067684 1.00 PTPN1 (0.67) PTPN1FASNKDM4ECNR1CNR2
SCHEMBL2453148 1.00 PTPN1 (0.67) PTPN1FASNKDM4ECNR1CNR2
SCHEMBL21411170 1.00 PTPN1 (0.67) PTPN1FASNKDM4ECNR1CNR2
SCHEMBL1614408 1.00 PTPN1 (0.67) PTPN1FASNKDM4ECNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200155575-A1 PHARMACEUTICAL COMPOSITION AND METHODS LIPOCINE INC. (US) 2020-05-21 US disclosed
US-20190269700-A1 PHARMACEUTICAL COMPOSITION AND METHODS LIPOCINE INC. (US) 2019-09-05 US disclosed
US-20180104257-A1 (17-ß)-3-Oxoandrost-4-En-17-Yl Undecanoate Compositions and Methods of Their Preparation and Use LIPOCINE INC. (US) 2018-04-19 US disclosed
US-20180078568-A1 PHARMACEUTICAL COMPOSITION AND METHODS LIPOCINE INC. (US) 2018-03-22 US disclosed
EP-3185873-A1 PHARMACEUTICAL COMPOSITION AND METHODS Lipocine Inc. (US) 2017-07-05 EP disclosed
US-20160193225-A1 (17-ß)-3-OXOANDROST-4-EN-17-YL UNDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE LIPOCINE INC. (US) 2016-07-07 US disclosed
US-20160184324-A1 PHARMACEUTICAL COMPOSITION AND METHODS LIPOCINE INC. (US) 2016-06-30 US disclosed
WO-2016033611-A1 (17-β)-3-OXOANDROST-4-EN-17-YL UNDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE LIPOCINE INC. (US) 2016-03-03 WO disclosed
WO-2016033536-A1 PHARMACEUTICAL COMPOSITION AND METHODS LIPOCINE INC. (US) 2016-03-03 WO disclosed